NFKB1 heterozygous and variant genotypes were associated with breast cancer risk in invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS), but not in invasive lobular carcinoma (ILC). This evidence concerns the gene NFKB1 and invasive ductal breast carcinoma.